Testing effectiveness (Phase 2)Ended earlyNCT00693472
What this trial is testing
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Who this might be right for
Akathisia, Drug-InducedAntipsychotic AgentsMovement Disorders
Merck Sharp & Dohme LLC 46